PAM
ARNA

Premier Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Premier Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,200
Closed -$63K – 97
2013
Q3 		$63K Buy
+1,200
New +$80.6K 0.02% 93

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Premier Asset Management's ARNA Position: Q4 2013 in Review

Premier Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2013, closing a stake of 1,200 shares — an estimated $63K sold.

Premier Asset Management first reported a position in ARNA in Q3 2013 and held it in 1 quarter. The position peaked at $63K in Q3 2013. 134 funds tracked by Wall St. Rank hold ARNA as of Q4 2013.

  • Premier Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Premier Asset Management sold 1,200 Arena Pharmaceuticals Inc shares in Q4 2013, an estimated $63K.
  • Premier Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 1 quarter.
  • Premier Asset Management's Arena Pharmaceuticals Inc position peaked at $63K in Q3 2013.
  • 134 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2013.

Based on Premier Asset Management's 13F filing for Q4 2013, filed 27 Jan 2014.